No insider purchase over the last 90 days. The latest was filed 27 Feb 2025.
Headquartered in Northfield, United States, Stepan Co belongs to the Chemicals & Materials sector and traces its origins to 1932. Filings by its managers are published through SEC (Form 4). The last twelve months, up to 18 October 2026, brought 23 filings signed by 8 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
With 23 filings in twelve months, the company is more active than the median of 19 filings across the 5,811 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 4 purchases and 14 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 2.33 bn USD and net income at 46.9 m USD; the dividend was 1.55 USD per share.
Over the last twelve months, not one insider purchase of Stepan Co stock was filed. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 216 declarations
Stepan Co. (NYSE: SCL) is a U.S.-based specialty chemicals company listed in the United States on the NYSE/NASDAQ market context referenced here, with headquarters in Northbrook, Illinois, United States. The company has a long operating history of more than 80 years and states that it was incorporated under the laws of Delaware on February 19, 1959, underscoring both its legacy and its evolution into a modern public industrial business. ([stepan.gcs-web.com](https://stepan.gcs-web.com/corporate-profile-2?utm_source=openai))
Stepan operates through three reportable segments: Surfactants, Polymers, and Specialty Products. Surfactants are the core of the franchise: Stepan is a major merchant producer of surfactants, which are essential ingredients in laundry detergents, hard-surface cleaners, disinfectants, shampoos, body wash, and a range of industrial, agricultural, and oilfield applications. The Polymers segment includes polyester polyols, polyurethane systems, and phthalic anhydride, supporting coatings, adhesives, foams, insulation, and construction-related materials. Specialty Products covers chemistries used in food, flavoring, nutritional supplements, and pharmaceutical applications. ([stepan.com](https://www.stepan.com/you-stepan/about-stepan-company.html?utm_source=openai))
From a competitive standpoint, Stepan occupies a specialized niche within the broader chemical industry. Management notes that the company does not have one exact peer that matches its business mix, reflecting the specificity of its product portfolio and end-market exposure. That differentiation matters: the company combines formulation expertise, customer-specific solutions, and process chemistry capabilities in sulfonation, alkoxylation, and phosphorylation. Its product set serves household, institutional and industrial cleaning, personal care, agriculture, oilfield, coatings, adhesives, sealants, elastomers, and other specialty applications. ([stepan.gcs-web.com](https://stepan.gcs-web.com/corporate-profile-2?utm_source=openai))
Geographically, Stepan has a global footprint and serves customers in the United States as well as internationally, including France, Poland, the United Kingdom, Brazil, and Mexico. This international manufacturing and sales presence helps the group stay close to key customers and diversify demand across regions and cycles. ([stockanalysis.com](https://stockanalysis.com/stocks/scl/company/?utm_source=openai))
Recent company developments include the release of its 2025 annual report and continued emphasis on innovation, sustainability, and operational execution. One notable strategic move was the 2022 agreement to acquire the surfactant business and related assets of PerformanX Specialty Chemicals, a transaction intended to add flexible capacity and strengthen Stepan’s position in surfactants and polymers. For investors, SCL stands out as a relatively focused specialty-chemical platform with a defensive end-market mix, recurring industrial demand, and a long-standing position in formulation-driven markets. ([stepan.gcs-web.com](https://stepan.gcs-web.com/financial-reports?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Northfield, United States · Founded: 1932 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | 2.33 bn USD | 46.9 m USD | 2.05 USD | 1.55 USD | 10-K |
| Dec 2024 | 2.18 bn USD | 50.4 m USD | 2.20 USD | 1.51 USD | 10-K |
| Dec 2023 | 2.33 bn USD | 40.2 m USD | 1.75 USD | 1.47 USD | 10-K |
| Dec 2022 | 2.77 bn USD | 147.2 m USD | 6.38 USD | 1.37 USD | 10-K |
| Dec 2021 | 2.35 bn USD | 137.8 m USD | 5.92 USD | 1.25 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.